Given the unique requirements of Fingolimod, Taro will be launching the TaroCares® Program to support our product and minimize any disruption to Patients, Physicians, or Pharmacists.

To enroll a patient for support or to schedule first-dose observation please call 1.833.618.0571

Release Date: 
Monday, November 4, 2019